Oceanpine Merger Sub to merge with LakeShore Biopharma in a $37m deal.

Synopsis

Oceanpine Merger Sub, a wholly owned subsidiary of Oceanpine Skyline, agreed to merge with LakeShore Biopharma, a global biopharmaceutical company, in a $37m deal.

Principals

target

Lakeshore Biopharma Co

bidder

Oceanpine Merger Sub

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context